TRB - Trademark Details
Status: 700 - Registered
Serial Number
79284012
Registration Number
6258760
Word Mark
TRB
Status
700 - Registered
Status Date
2021-02-02
Filing Date
2020-03-11
Registration Number
6258760
Registration Date
2021-02-02
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260112, 261710, 261725 - Circles with bars, bands and lines. Zig-zag line(s). Other lines, bands or bars.
Published for Opposition Date
2020-11-17
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
LAM, HAI-LY HUYNH
Statements
Indication of Colors claimed
The color(s) blue is/are claimed as a feature of the mark.
Description of Mark
The mark consists of a circular design outlined in blue containing zig-zag bands in blue followed to the right by the letters "TRB" in blue. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Goods and Services
pharmaceuticals, namely, anti-neurodegenerative, anti-neurotrophic, anti-antineurotoxic, neuroprotective and neurorestorative effect agents; pharmaceuticals, namely, immunopharmaceuticals; medical and veterinary preparations, namely, preparations for use in treating joint disease in horses, and antioxidants; pharmaceutical and medicinal preparations and substances for treating and preventing ophthalmic, ocular, neurological, metabolic, dermatological, arthritic, cognitive, or sexual dysfunction-related conditions, disorders or diseases; pharmaceutical and medicinal preparations and substances for treating and preventing joint, ligament, tendon, cartilage, bone, damaged skin or tissue-related conditions, disorders or diseases; pharmaceutical and medicinal preparations and substances for the treatment of central or peripheral nervous system-related, spinal cord-related, or early stages of traumatic or acute vascular injury-related disorders and diseases; pharmaceutical and medicinal preparations and substances for the treatment of pain, inflammation, physical lesions, and wounds; analgesics; anti-inflammatories; medicines for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; medicines for use as surgical aid during cataract surgery procedures; medicines for the treatment of osteoarthritis and rheumatoid arthritis; medicines for the prevention of osteoporosis; medicines for the treatment of musculo-skeletal conditions, disorders or diseases; medicines for the treatment of tendinopathy; medicines for joint recovery after arthroscopy; medicines to help assist with the regeneration of ligament and tendon fibers; medicines for the treatment of immune system related diseases and disorders; medicines for the treatment of blepharitis, glaucoma, and degenerative eye pathologies; pharmaceutical drugs for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; pharmaceutical drugs for use as surgical aid during cataract surgery procedures; pharmaceutical drugs for the treatment of osteoarthritis and rheumatoid arthritis; pharmaceutical drugs for the prevention of osteoporosis; pharmaceutical drugs for the treatment of musculo-skeletal conditions, disorders or diseases; pharmaceutical drugs for the treatment of tendinopathy; pharmaceutical drugs for joint recovery after arthroscopy; pharmaceutical drugs to help assist with the regeneration of ligament and tendon fibers; pharmaceutical drugs for the treatment of immune system related diseases and disorders; pharmaceutical drugs for the treatment of blepharitis, glaucoma, and degenerative eye pathologies; therapeutic drugs for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; therapeutic drugs for use as surgical aid during cataract surgery procedures; therapeutic drugs for the treatment of osteoarthritis and rheumatoid arthritis; therapeutic drugs for the prevention of osteoporosis; therapeutic drugs for the treatment of musculo-skeletal conditions, disorders or diseases; therapeutic drugs for the treatment of tendinopathy; therapeutic drugs for joint recovery after arthroscopy; therapeutic drugs to help assist with the regeneration of ligament and tendon fibers; therapeutic drugs for the treatment of immune system related diseases and disorders, and therapeutic agents for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; therapeutic agents for use as surgical aid during cataract surgery procedures; therapeutic agents for the treatment of osteoarthritis and rheumatoid arthritis; therapeutic agents for the prevention of osteoporosis; therapeutic agents for the treatment of musculo-skeletal conditions, disorders or diseases; therapeutic agents for the treatment of tendinopathy; therapeutic agents for joint recovery after arthroscopy; therapeutic agents to help assist with the regeneration of ligament and tendon fibers; therapeutic agents for the treatment of immune system related diseases and disorders; transdermal patches featuring vitamins for increasing energy for medical use; biological cartilage, bone or skin tissue intended for subsequent implantation; biological preparations for medical or veterinary use, namely, for the treatment of infectious diseases; sanitary preparations for medical purposes; dietetic food and substances in the nature of food supplements and vitamins supplements all adapted for medical or veterinary use; food for babies; dietary supplements for humans and animals; meal replacements, namely, meal replacement bars adapted for medical use and meal replacement beverages adapted for medical use, and dietetic beverages adapted for medical and veterinary use; materials for dressings, namely, dressings for wounds, burns or surgery, adhesive bandages, gauze for dressings, pledgets; disinfectants
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-04-27
Primary Code
005
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
33
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
33
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
33
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
33
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Andrew M. Smith
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Prior Registration | 5045303 |
International Registrations
International Registration Number
1527026
International Registration Date
2020-03-11
International Publication Date
2020-04-23
International Renewal Date
2030-03-11
Auto Protection Date
2021-10-23
International Status
001 - Request for extension of protection established
International Status Date
2020-04-23
Priority Claimed In
True
Priority Claimed Date
2019-09-30
First Refusal In
True
Trademark Events
Event Date | Event Description |
2020-04-23 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2020-04-27 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-05-01 | APPLICATION FILING RECEIPT MAILED |
2020-05-21 | ASSIGNED TO EXAMINER |
2020-05-28 | NON-FINAL ACTION WRITTEN |
2020-05-29 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2020-06-30 | REFUSAL PROCESSED BY MPU |
2020-06-30 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2020-07-18 | REFUSAL PROCESSED BY IB |
2020-10-07 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-10-07 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-10-08 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-10-13 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-10-28 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-11-17 | PUBLISHED FOR OPPOSITION |
2020-11-17 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-02-02 | REGISTERED-PRINCIPAL REGISTER |
2021-05-02 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2021-05-05 | FINAL DISPOSITION PROCESSED |
2021-05-05 | FINAL DISPOSITION NOTICE SENT TO IB |
2021-05-18 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2021-05-18 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-05-18 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2021-05-30 | FINAL DECISION TRANSACTION PROCESSED BY IB |